ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "ASCO 2024 Plenary: ADRIATIC Trial in Limited Stage Small Cell Lung Cancer "
Episode Synopsis
This week’s episode will discuss updates from ASCO 2024 next with the practice changing ADRIATIC trial presented by Dr. Spigel during the plenary: Durvalumab as consolidation treatment for patients with limited-stage small-cell lung cancer (LS-SCLC).
More episodes of the podcast Two Onc Docs
Hodgkin Lymphoma 2025 UPDATE
24/11/2025
Anal Cancer 2025 UPDATE
17/11/2025
Urothelial ESMO 2025 Updates
10/11/2025
Board Review Tidbits
03/11/2025
Porphyria
27/10/2025
Metastatic Breast Cancer 2025 UPDATE
20/10/2025
Localized Breast Cancer 2025 UPDATE
13/10/2025
In God we trust